TGA
Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026 – external site, which commenced on 1 March 2026. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025 – external site.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 22 changed ingredients is below:
| Substance name | Change |
|---|---|
| Polyisobutylene | Change |
| Stannic oxide | Change |
| Calcium hydroxycitrate | Change |
| Garcinia gummi-gutta | Change |
| Garcinia quaesita | Change |
| Hydroxycitrate complex | Change |
| Hydroxycitric acid | Change |
| Parsley herb dry | Change |
| Parsley herb oil | Change |
| Parsley herb powder | Change |
| Parsley seed oil | Change |
| Petroselinum crispum | Change |
| Phenoxyethanol | Change |
| Potassium hydroxycitrate | Change |
| Rue oil | Change |
| Ruta graveolens | Change |
| Sodium hydroxycitrate | Change |
| Xanthium sibiricum | Change |
| Xanthium strumarium | Change |
| Lauryl methacrylate/sodium methacrylate crosspolymer dispersion (40 per cent) | Change |
| Sorbitan distearate | Change |
| Stearoyl glutamic acid | Change |
/Public Release. View in full here.
